Literature DB >> 8372031

Thyroid C cells in the DiGeorge anomaly: a quantitative study.

S Pueblitz1, A G Weinberg, J Albores-Saavedra.   

Abstract

The developmental field defect in the DiGeorge anomaly (DGA) principally affects derivatives of the third and fourth branchial pouches (areas containing a large population of cephalic neural crest cells), including the ultimobranchial body (UB), the reputed source of thyroid calcitonin-producing cells (C cells) in humans. To evaluate the content of C cells in children with DGA, sections of the thyroid in 16 cases of DGA (group I) (8 incomplete and 8 complete forms) and 16 age-matched controls (group II) were stained by immunoperoxidase for calcitonin and chromogranin. Eleven of 16 (69%) cases in group I [4 of 8 (50%) of the complete and 7 of 8 (88%) of of the incomplete cases] and 14 of 16 (88%) of group II exhibited positive-staining cells for both markers, either individually or in small clusters within the follicular epithelial basement membrane. The average number of C cells per high-power field (HPF) (400x) for group I was 1.6 +/- 0.9 and for group II 4.9 +/- 1.7 (P < .005). Although the percentage of positive incomplete DGA cases was the same as that of the control cases, the average number of C cells/HPF was 2.0 +/- 1.1 and similar to that of complete DGA cases (1.2 +/- 0.6). These results demonstrated that C cells are present in the thyroid of patients with DGA more frequently than expected, although in deficient numbers when compared quantitatively to age-matched controls showing a normal infantile pattern of thyroid C cell distribution. Although this observation confirms that there is deficiency of thyroid C cell development in DGA and is in keeping with the assumption that the cells are of neural crest origin, our data raise the possibility of an additional source of C cells, perhaps from thyroid endoderm, in a manner analogous to the endocrine cells of the gut and respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372031     DOI: 10.3109/15513819309048236

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  9 in total

Review 1.  Review: the role of neural crest cells in the endocrine system.

Authors:  Meghan Sara Adams; Marianne Bronner-Fraser
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 2.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 3.  [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].

Authors:  S Ting; S Synoracki; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 4.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

Review 5.  Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Authors:  Ying-Hsia Chu; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 6.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

7.  Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases.

Authors:  S F Lax; A Beham; D Kronberger-Schönecker; W Langsteger; H Denk
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 8.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

9.  Revising the embryonic origin of thyroid C cells in mice and humans.

Authors:  Ellen Johansson; Louise Andersson; Jessica Örnros; Therese Carlsson; Camilla Ingeson-Carlsson; Shawn Liang; Jakob Dahlberg; Svante Jansson; Luca Parrillo; Pietro Zoppoli; Guillermo O Barila; Daniel L Altschuler; Daniela Padula; Heiko Lickert; Henrik Fagman; Mikael Nilsson
Journal:  Development       Date:  2015-09-22       Impact factor: 6.868

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.